Overview
- Bemotrizinol is a broad‑spectrum UV filter that protects against both UVA and UVB rays and is described by the FDA as photostable with low skin absorption and rare irritation.
- The proposal would make the first new UV filter available in the U.S. in more than 25 years if finalized.
- An FDA spokesperson said the agency anticipates issuing a final order in summer or fall 2026 following a 45‑day public comment period.
- FDA materials indicate the ingredient could be considered safe for children 6 months and older, alongside zinc oxide and titanium dioxide.
- Bemotrizinol has long been used in Europe, Australia and parts of Asia, highlighting how the U.S. drug‑style regulation of sunscreen filters has limited domestic options.